Biomedicine
/
Eastern Norway

Pci Biotech AS

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
  • Finance
    Total revenues: 10.25
    Operating profit: -40.249
    Operating profit before tax: -43.124
    Total assets: 57.634
    Total equity: 14.739
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Per Edvard Walday

    Board Members:
    Anders Høgset
    Ronny Skuggedal

    General Manager:
    Per Edvard Walday

    Subsidiary companies:
    Largest shareholders:
    N/A
    Biomedicine, Medicinal products, Pharmaceutical & Medical Chemical Products, Pharmaceutical & Medicinal Chemicals, Pharmaceutical articles, Research and experimental development services, Terapeutica, Therapeutic agents,